About the IMS

The International Myeloma Society (IMS) is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.

The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners. IMS is governed by a Board of Directors representing practices from around the world and encourages and promotes the study of this expanding field through its annual International Myeloma Meeting.

About the Annual Meeting

The International Myeloma Society Meeting is the defining annual meeting in myeloma with a focus on both the basic, preclinical and the clinical aspects. This year’s program includes:

  • Four thematic sessions: 
    • Precursor Disease
    • Risk Adaptation Management
    • Immunotherapy
    • Relapse within 1-3 lines of therapy
  • Talks and symposia on pressing topics led by the KOL of the myeloma community
  • Keynote addresses
  • Joint sessions with regulatory agencies and other organizations
  • Meet the Expert sessions
  • Oral Abstracts (on Basic Biology, Preclinical Trials, and Clinical Studies)
  • Poster presentations and discussion sessions

Land Acknowledgement

The International Myeloma Society acknowledges the land this event is held on is the traditional territory of many nations including the Mississaugas of the Credit, the Anishnabeg, the Chippewa, the Haudenosaunee and the Wendat peoples and is now home to many diverse First Nations, Inuit and Métis peoples. We also acknowledge that Toronto is covered by Treaty 13 with the Mississaugas of the Credit.

22nd International Myeloma Society Annual Meeting
September 17-20, 2025 ~ Toronto, Ontario, Canada